By now, you’ve probably heard about the many benefits of CBD oil and maybe you have considered using products containing the cannabis compound. But you may be wondering — what is CBD, exactly?
There’s a lot of confusion out there about CBD and how it affects the human body. Considering the endocannabinoid system was only discovered 25 years ago, we are just beginning to learn about cannabidiol and its abilities.
But so far, the research is promising, which explains why so many people are becoming interested in using this thousand-year-old natural remedy for their own health needs.
A Randomized, Double-Blind, Placebo- Controlled, Intent to Treat Study
Hypothalamic dysfunction has been suggested in Fibromyalgia (FMS) and Chronic Fatigue Syndrome (CFS). This dysfunction may result in disordered sleep, subclinical hormonal deficiencies, and immunologic changes. Our previously published open trial showed that patients usually improve by using a protocol which treats all the above processes simultaneously. The current study examines this protocol using a randomized, double-blind design with an intent-to-treat analysis.
I believe conventional medicine has it all wrong when it comes to treating autoimmune conditions.
Autoimmune conditions affect over 50 million Americans, a large percentage of whom are women. Autoimmune diseases are now the third leading chronic disease in the country right behind heart disease and cancer. They are a top ten leading cause of death in women under the age of 65, and they come in more than 80 different varieties, including rheumatoid arthritis, type I diabetes, Lupus, thyroid disease, psoriasis, multiple sclerosis, and more. Yet, it takes an average of six-to-ten doctors and five years to receive one of these autoimmune diagnoses. What is conventional medicine doing wrong?
Don't know your blood type?
Are you ready to begin the journey into GenoType? Get the information you need, with our easy to use home testing kits. Each kit has been specially designed by Dr. Peter D'Adamo and contains all the tools you'll need to quickly and easily determine your blood type, GenoType, or secretor status - all without trips to the doctor, waiting days for test results, or expensive lab fees.
Researchers at the University of Toronto and UC San Francisco have discovered that the intestine is the source of immune cells that reduce brain inflammation in people with multiple sclerosis (MS), and that increasing the number of these cells blocks inflammation entirely in a preclinical model of the disease.
The cells in question are plasma cells – white blood cells that originate as B cells in the bone marrow but change their behavior when triggered by microbes in the gut. Studying mice and samples from human MS patients, the researchers found that plasma cells that reside in the gut and produce Immunoglobulin A (IgA) antibodies appear to migrate to the central nervous system and produce an anti-inflammatory effect during MS flare-ups.
MS is an autoimmune disease, driven by other types of immune cells (including B and T cells) that attack myelin, the protective coating that surrounds nerve fibers. Recent clinical studies have shown drugs that target B cells mitigate MS, while those that target plasma cells make the disease worse. The current study offers an explanation for these divergent results.
...and the Lifelong Consequences of Trauma
Many people can identify a person in their lives who struggles with a chronic illness like heart disease, diabetes, or hypertension. Most people also know someone who struggles with mental illness, substance abuse, or relationships in general. Traditionally, the health care system would point to high-risk behaviors such as poor diet, drug use, or a sedentary lifestyle as the primary causal factors. Questions for patients have focused on “What’s wrong with you?” rather than “What happened to you?” A 1998 study from the Centers for Disease Control and Prevention (CDC) and Kaiser Permanente is leading to a paradigm shift in the medical community’s approach to disease. This study of more than 17,000 middle-class Americans documented quite clearly that adverse childhood experiences (ACEs) can contribute significantly to negative adult physical and mental health outcomes and affect more than 60% of adults.1,2 This continues to be reaffirmed with more recent studies.